Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 7Recruiting 6Active not recruiting 6Unknown 3Terminated 3Withdrawn 2

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Genitourinary 3Thoracic 2Dermatologic 2Sarcoma 1Head & Neck 1Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 31Melanoma 20Neoplasms 13Breast Neoplasms 11Pancreatic Neoplasms 9Lung Neoplasms 9Head and Neck Neoplasms 9Triple Negative Breast Neoplasms 8Stomach Neoplasms 8Squamous Cell Carcinoma of Head and Neck 8Ovarian Neoplasms 8Neoplasm Metastasis 8Colorectal Neoplasms 7Carcinoma, Renal Cell 7Carcinoma, Hepatocellular 6Prostatic Neoplasms 4Hodgkin Disease 4Glioblastoma 4Carcinoma, Transitional Cell 4Carcinoma 4Uterine Cervical Neoplasms 3Liver Neoplasms 3Kidney Neoplasms 3Esophageal Squamous Cell Carcinoma 3Esophageal Neoplasms 3Adenocarcinoma 3Small Cell Lung Carcinoma 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Neoplasms, Squamous Cell 2Mesothelioma 2

Interventions

aldesleukin 9Sunitinib 5Interferon-alpha 4Chemotherapy, Adjuvant 4pembrolizumab 3Vincristine 3Neoadjuvant Therapy 3Dactinomycin 3Cyclophosphamide 3Bevacizumab 3sargramostim 2fludarabine phosphate 2Robotic Surgical Procedures 2Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2Laparoscopy 2Gene Expression Profiling 2Fluorouracil 2Etoposide 2Electroporation 2Doxorubicin 2Carboplatin 2Blood Specimen Collection 2Amplified Fragment Length Polymorphism Analysis 2tremelimumab 1toripalimab 1temsirolimus 1spartalizumab 1pazopanib 1orantinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Kidney Neoplasms × pembrolizumab × Clear all
NCT05708950 2023-07-13

A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)

Kineta Inc.

Phase 1/2 Unknown
314 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Breast Neoplasms, Carcinoma, Colonic Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms, Thyroid Neoplasms, Uterine Neoplasms

NCT03280667 2023-03-29

KEYPAD

Australian and New Zealand Urogenital and Prostate Cancer Trials Group

Phase 2 Unknown
59 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT04107168 2023-02-16

Microbiome Immunotherapy Toxicity and Response Evaluation

Cambridge University Hospitals NHS Foundation Trust

Unknown
1,800 enrolled
DermatologicGenitourinaryThoracic

Kidney Neoplasms, Lung Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡